Synergistic anticancer effects of andrographolide and paclitaxel against A549 NSCLC cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergistic anticancer effects of andrographolide and paclitaxel against A549 NSCLC cells
Authors
Keywords
-
Journal
PHARMACEUTICAL BIOLOGY
Volume 54, Issue 11, Pages 2629-2635
Publisher
Informa UK Limited
Online
2016-05-09
DOI
10.1080/13880209.2016.1176056
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Paclitaxel-loaded Nanoparticles on the Viability of Human Hepatocellular Carcinoma HepG2 Cells
- (2015) Zhi-Hong Hou et al. Asian Pacific Journal of Cancer Prevention
- Antitumor activity of paclitaxel is significantly enhanced by a novel proapoptotic agent in non–small cell lung cancer
- (2015) Syed S. Razi et al. JOURNAL OF SURGICAL RESEARCH
- The Promise and Perils of Antioxidants for Cancer Patients
- (2014) Navdeep S. Chandel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synergistic effect of paclitaxel and epigenetic agent phenethyl isothiocyanate on growth inhibition, cell cycle arrest and apoptosis in breast cancer cells
- (2013) Katherine Liu et al. Cancer Cell International
- Experimental designs for drug combination studies
- (2013) B. Almohaimeed et al. COMPUTATIONAL STATISTICS & DATA ANALYSIS
- Solid lipid nanoparticles of anticancer drug andrographolide: formulation,in vitroandin vivostudies
- (2013) Rabea Parveen et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Synergistic Interaction of Paclitaxel and Curcumin with Cyclodextrin Polymer Complexation in Human Cancer Cells
- (2013) Ali O. Boztas et al. MOLECULAR PHARMACEUTICS
- Silver nanoparticles induce toxicity in A549 cells via ROS-dependent and ROS-independent pathways
- (2012) Porntipa Chairuangkitti et al. TOXICOLOGY IN VITRO
- A Systematic Review of Economic Evaluations in Second and Later Lines of Therapy for the Treatment of Non-Small Cell Lung Cancer
- (2012) Anne Jäkel et al. Applied Health Economics and Health Policy
- 1′S-1′-acetoxyeugenol acetate
- (2011) Lionel Lian Aun et al. ANTI-CANCER DRUGS
- Signal transduction by reactive oxygen species
- (2011) Toren Finkel JOURNAL OF CELL BIOLOGY
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Mitochondrial-Mediated Apoptosis in Lymphoma Cells by the Diterpenoid Lactone Andrographolide, the Active Component of Andrographis paniculata
- (2010) S. Yang et al. CLINICAL CANCER RESEARCH
- Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway
- (2010) Yi-Chieh Lee et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Andrographolide down-regulates hypoxia-inducible factor-1α in human non-small cell lung cancer A549 cells
- (2010) Hui-Hsuan Lin et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now